Market Research Logo

Global Biologics Drug Discovery Market Analysis and Forecast, (2017-2025) (Focus on Method/Phase, Product Type, Manufacturer Type and Competitive Landscape)

Global Biologics Drug Discovery Market Analysis and Forecast, (2017-2025) (Focus on Method/Phase, Product Type, Manufacturer Type and Competitive Landscape)

The pharmaceutical Industry is a multibillion market consisting of innovator drugs & generics. The pharmaceutical market consists of a companies involved in the research, development, manufacturing and commercialization of drugs for human & animal use. Geographically, biologics have registered near double digit annual growth rate, whereas, the pharmaceutical drugs registered only single digit annual growth rate, in the past five years. This double digit growth was largely fuelled by the substantial investments of the major pharmaceutical companies, who realized the potential of the market quite early. Biologics are defined as pharmaceutical products obtained from living cells or micro-organisms. These are complex & large molecules consisting of proteins, peptides, nucleic acids, sugars, cellular structures or a combination of these.

The biologics drug discovery involves target identification, hit-to-lead stage, lead identification & optimization. Technologies used for the development of biologics include genomics, proteomics, microarrays, cell cultures, phage display technologies and monoclonal antibody technologies among others. The market analysis includes an in-depth examination of the key ecosystem players and key strategies & developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities and challenges) and industry analysis.

The purpose of the study is to gain a holistic view of the biologics drug discovery market in terms of various factors influencing it such as recent trends, technological advancements, and regulatory aspects of the market. The scope of this report is centred upon conducting a detailed study of the solutions allied with the biologics drug discovery market. The market has been segmented into ‘product’, ‘method’, ‘manufacture’ and ‘geographical regions’. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.

This research report aims at answering various aspects of the global biologics drug discovery market with the help of key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that is going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the global biologics drug discovery market and assesses the factors governing the same.

The answers to the following key questions can be derived from this report:

  • What are the major market drivers, challenges and opportunities in the global biologics drug discovery market and their case studies?
  • How the biologics drug discovery market evolve and what did is its scope in the future?
  • What is the market share of the leading segments and sub-segments of the global biologics drug discovery market in 2016 and 2025?
  • How will each segment of the global biologics drug discovery market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2025?
  • What are the influencing factors that may affect the market share of the key players?
  • How will the industry evolve during the forecast period between 2016 and 2025?
  • What are the key developmental strategies implemented by the key players to stand out in this market?
  • What will be the growth rate of the outsourced manufacturing segment during the forecast period?
  • Who are the key outsourced manufacturers of the biologics drug discovery market market?
  • How the market has been segmented on the basis of phase/method? Which method is highly adopted in the biologics drug discovery process?
  • Which technologies have been covered in the Target Identification phase?
  • What will be the value of oncology biologics drug discovery segment by 2025?
  • Which geographical location will contribute to the highest sales of biologics?
  • In Europe, which country is dominating the biologics drug discovery market? Also, which country will show the highest growth rate?
The key players which have significant contributions to the biologics drug discovery market are Albany Molecular Research Inc., GenScript, F. Hoffmann-La Roche AG, Pfizer Inc., Novartis AG, Sanofi, Merck & Co., Inc., Johnson & Johnson, GlaxoSmithKline plc, AstraZeneca plc, AbbVie Inc., Amgen Inc., Lilly, Bristol-Myers Squibb, Novo Nordisk, Merck KGaA, Allergan, Plc, Boehringer Ingelheim GmbH, Astellas Pharma Inc., Teva Pharmaceutical Industries Ltd., and Bayer AG, and Biocon Ltd. among others.


Executive Summary
1 Report Scope
1.1 Scope of the Report
1.2 Global Biologics Drug Discovery Market Segmentation
1.3 Key Learnings
1.4 Research Methodology
1.4.1. Data Triangulation
1.4.2. Key Data Points From Secondary Sources
1.4.3. Key Data Points From Primary Sources
1.4.4. Top-Down Approach (Segmental Analysis)
1.4.5. Bottom-Up Approach (Segmental Analysis)
1.4.6. Assumptions and Limitations
1.4.7. Data and Prediction Modelling
2 Market Overview
2.1 Introduction
2.2 Market Dynamics
2.2.1. Market Drivers
2.2.2. Market Challenges
2.2.3. Market Opportunities
3 Industry Insights
3.1. Regulatory Scenario
3.2. Patent Landscape
4 Competitive Landscape
4.1 Share of Key Developments & Strategies
4.1.1. Collaboration/ Partnership/ Joint Venture/ Licensing Agreement
4.1.2. Mergers & Acquisitions
4.1.3. Business Expansion
4.1.4. Products/Platform/Services Launch
4.1.5. Others
4.2. Porter's Five Forces Analysis
4.2.1. Bargaining Power of Suppliers
4.2.2. Bargaining Power of Buyers
4.2.3. Threat of New Entrants>
4.2.4. Threat of Substitutes
4.2.5. Intensity of Competitive Rivalry
5 Global Biologics Drug Discovery Market, by Product
5.1. Small Molecule Vs. Biologicals
5.2. Biologicals
5.2.1. Monoclonal Antibodies
5.2.2. Recombinant Proteins
5.2.3. Other biologics
6 Global Biologics Drug Discovery Market, by Phase
6.1. Target Identification/Validation
6.1.1. Functional Genomics/Proteomics
6.1.2. Computational Approach/In-silico
6.1.3. Cell based Assay
6.1.4. Knock out studies/CRISPR/Cas9
6.1.5. Animal/Disease Based Models
6.2. Hit Generation
6.3. Lead Identification
6.4. Lead Optimization
7 Global Biologics Drug Discovery Market, by Manufacture Type
7.1. Type of Manufacturing
7.1.1. In-House Manufacturing
7.1.2. Advantages of Outsourcing Development
7.1.3. Outsourced Manufacturing
8 Global Biologics Drug Discovery Market, by Geography
8.1. Introduction
8.2. North America
8.3. Europe
8.4. Asia-Pacific
8.5 Rest Of the World
9 Company Profiles
9.1. Abbvie Inc.
9.1.1. Overview
9.1.2. Product Portfolio
9.1.3. Financials
9.1.3.1 Financial Summary
9.1.4. Abbvie Inc.: SWOT Analysis
9.2. Albany Molecular Research Inc.
9.2.1. Overview
9.2.2. Product/Services Portfolio
9.2.3. Financials
9.2.3.1 Financial Summary
9.2.4. Albany Molecular Research Inc.: SWOT Analysis
9.3. Allergan plc.
9.3.1. Overview
9.3.2. Product Portfolio
9.3.3. Financials
9.3.3.1 Financial Summary
9.3.4. Allergan plc.: SWOT Analysis
9.4. Amgen Inc.
9.4.1. Overview
9.4.2. Product Portfolio
9.4.3. Financials
9.4.3.1 Financial Summary
9.4.4. Amgen Inc.: SWOT Analysis
9.5. Aptuit
9.5.1. Overview
9.5.2. Product/Services Portfolio
9.5.3. Financials
9.5.3.1 Financial Summary
9.5.4. Amgen Inc.: SWOT Analysis
9.6. Atellas Pharma Inc.
9.6.1. Overview
9.6.2. Product Portfolio
9.6.3. Financials
9.6.3.1. Financial Summary
9.6.4. Astellas Pharma Inc.: SWOT Analysis
9.7. AstraZeneca PLC
9.7.1. Overview
9.7.2. Product Portfolio
9.7.3. Financials
9.7.3.1. Financial Summary
9.7.4. AstraZeneca Plc: SWOT Analysis
9.8. Bayer AG
9.8.1. Overview
9.8.2. Product Portfolio
9.8.3. Financials
9.8.3.1. Financial Summary
9.8.4. Bayer AG: SWOT Analysis
9.9. Biocon Ltd.
9.9.1. Overview
9.9.2. Product Portfolio
9.9.3. Financials
9.9.3.1. Financial Summary
9.9.4. Bayer AG: SWOT Analysis
9.10. Boehringer Ingelheim GmbH
9.10.1. Overview
9.10.2. Product Portfolio
9.10.3. Financials
9.10.3.1. Financial Summary
9.10.4. Boehringer Ingelheim GmbH : SWOT Analysis
9.11. BRISTOL-MYERS SQUIBB COMPANY
9.11.1. Overview
9.11.2. Product Portfolio
9.11.3. Financials
9.11.3.1. Financial Summary
9.11.4. BRISTOL-MYERS SQUIBB COMPANY: SWOT Analysis
9.12. Charles River Laboratories International, Inc.
9.12.1. Overview
9.12.2. Product/Services Portfolio
9.12.3. Financials
9.12.3.1. Financial Summary
9.12.4. Charles River Laboratories International Inc: SWOT Analysis
9.13. Eli Lilly and Company
9.13.1. Overview
9.13.2. Products Portfolio
9.13.3. Financials
9.13.3.1. Financial Summary
9.13.4. Eli Lilly and Company: SWOT Analysis
9.14. Evotec AG
9.14.1. Overview
9.14.2. Product/Services Portfolio
9.14.3. Financials
9.14.3.1. Financial Summary
9.14.4. Evotec AG: SWOT Analysis
9.15. F. Hoffmann-La Roche AG
9.15.1. Overview
9.15.2. Product Portfolio
9.15.3. Financials
9.15.3.1. Financial Summary
9.15.4. F. Hoffmann-La Roche AG: SWOT Analysis
9.16. GenScript
9.16.1. Overview
9.16.2. Product/Services Portfolio
9.16.3. Corporate Summary
9.16.4. GenScript: SWOT Analysis
9.17. Gilead Sciences Inc.
9.17.1. Overview
9.17.2. Product Portfolio
9.17.3. Financials
9.17.3.1. Financial Summary
9.17.4. Gilead Sciences Inc.: SWOT Analysis
9.18. GlaxoSmithKline Plc
9.18.1. Overview
9.18.2. Product Portfolio
9.18.3. Financials
9.18.3.1. Financial Summary
9.18.4. GlaxoSmithKline Plc: SWOT Analysis
9.19. JOHNSON & JOHNSON
9.19.1. Overview
9.19.2. Product Portfolio
9.19.3. Financials
9.19.3.1. Financial Summary
9.19.4. JOHNSON & JOHNSON: SWOT Analysis
9.20. Laboratory Corporation of America Holdings
9.20.1. Overview
9.20.2. Product/Services Portfolio
9.20.3. Financials
9.20.3.1. Financial Summary
9.20.4. Laboratory Corporation of America Holdings: SWOT Analysis
9.21. Merck KGaA
9.21.1. Overview
9.21.2. Product Portfolio
9.21.3. Financials
9.21.3.1. Financial Summary
9.21.4. Merck KGaA: SWOT Analysis
9.22. Merck & CO., Inc.
9.22.1. Overview
9.22.2. Product Portfolio
9.22.3. Financials
9.22.3.1. Financial Summary
9.22.4. Merck & CO., Inc.: SWOT Analysis
9.23. Novartis AG
9.23.1. Overview
9.23.2. Product Portfolio
9.23.3. Financials
9.23.3.1. Financial Summary
9.23.4. Novartis AG: SWOT Analysis
9.24. NOVO NORDISK
9.24.1. Overview
9.24.2. Product Portfolio
9.24.3. Financials
9.24.3.1. Financial Summary
9.24.4. NOVO NORDISK: SWOT Analysis
9.25. Pfizer Inc.
9.25.1. Overview
9.25.2. Product Portfolio
9.25.3. Financials
9.25.3.1. Financial Summary
9.25.4. Pfizer Inc.: SWOT Analysis
9.26. Sanofi
9.26.1. Overview
9.26.2. Product Portfolio
9.26.3. Financials
9.26.3.1. Financial Summary
9.26.4. Sanofi: SWOT Analysis
9.27. Teva Pharmaceuticals
9.27.1. Overview
9.27.2. Product Portfolio
9.27.3. Financials
9.27.3.1. Financial Summary
9.27.4. Teva Pharmaceuticals: SWOT Analysis
9.28. WuXi Apptec
9.28.1. Overview
9.28.2. Product/Services Portfolio
9.28.3. Corporate Summary
9.28.4. WuXi Apptec: SWOT Analysis
List of Tables
Global Biologics Drug Discovery Market (2016 & 2023)
Drug Approvals by FDA
Percentage of total regional population aged 65 years & above: 2015 & 2030
Regulatory Scenario across the world
Patent Landscape
Partnership/Collaboration/Joint Ventures/Licensing Agreements
Mergers & Acquisitions
Business Expansion
Products/Platform/Services Launch
Other-Funding, Milestones, Awards
Factors Affecting Bargaining Power of Suppliers
Factors Affecting the Bargaining Power of Buyers
Factors Affecting Threat of New Entrant
Factors Affecting the Threat of Substitutes
Factors Affecting the Intensity of Competitive Rivalry
Difference between Small Molecule and Biologics
Examples of marketed biological products.
Some of the marketed products with cells used
Some of the biologics drugs in different phases of development
Percentage of population aged 60 years or above
Percentages of population aged 60 or over.
Overview: AbbVie Inc.
Overview: Albany Molecular Research Inc.
Overview: Allergan plc.
Overview: Amgen Inc.
Overview: Aptuit
Overview: Astellas Pharma Inc.
Overview: AstraZeneca PLC
Overview: Bayer AG
Overview: Biocon Ltd.
Overview: Boehringer Ingelheim GmbH
Overview: BRISTOL-MYERS SQUIBB COMPANY
Overview: Charles River Laboratories International, Inc.
Overview: Eli Lilly and Company
Overview: Evotec AG
Overview: F. Hoffmann-La Roche AG
Overview: GenScript
Overview: GILEAD SCIENCES, INC.
Overview: GlaxoSmithKline Plc
Overview: JOHNSON & JOHNSON
Overview: Laboratory Corporation of America Holdings
Overview: Merck KGaA
Overview: Merck & CO., Inc.
Overview: Novartis AG
Overview: NOVO NORDISK
Overview: Pfizer Inc.
Overview: Sanofi
Overview: Teva Pharmaceuticals Industries Limited
Overview: WuXi Apptec
List of Figures
Global Biologics Drug Discovery Market Value, 2015-2025 ($Million)
Global Drug Discovery Market Value, 2015-2025 ($Million)
Global Biologics Drug Discovery Market, 2016-2025 ($Million), by phase
Global Biologic Drug Discovery Market by Manufacture Type, 2016
Global Biologic Drug Discovery Market by Manufacture Type, 2025
Global Biologics Drug Discovery Market, by Product Type, 2016
Global Biologics Drug Discovery Market, by Product Type, 2025
Global Biologics Drug Discovery Market Value by Geography, 2016 & 2025 ($Million)
Global Biologics Drug Discovery Market, by Geography, 2016
Global Biologics Drug Discovery Market, by Geography, 2025
Global Biologics Drug Discovery Market Segmentation
Research Methodology
Data Triangulation
Key Data Points From Secondary Sources
Key Data Points From Primary Sources
Top-Down Approach (Segmental Analysis)
Bottom-Up Approach (Segmental Analysis)
Assumptions and Limitations
Drug Discovery of Biologics
Share of Key Development & Strategies
Porter’s Five Forces Analysis
Drug Market by product type, 2016-2023 (in $Million)
Hybridoma technique of monoclonal antibody production
Methods of Humanization of Antibodies
Monoclonal Antibody Drug Discovery Market by product type, 2016-2025 (in $million)
Global monoclonal antibody target identification market, 2016-2025 (in $million)
Global monoclonal antibody hit generation/validation market, 2016-2025 (in $million)
Global monoclonal antibody lead identification market, 2016-2025 (in $million)
Global monoclonal antibody lead optimization market, 2016-2025 (in $million)
Factors affecting choice of cells
Recombinant Proteins Drug Discovery Market by method type, 2016-2025 (in $Million)
Global recombinant protein target identification market, 2016-2025 (in $million)
Global recombinant protein hit generation/validation market, 2016-2025 (in $million)
Global recombinant protein lead identification market, 2016-2025 (in $million)
Global recombinant protein lead optimization market, 2016-2025 (in $million)
Global Biologics Drug Discovery Market, by phase, 2016-2025 (in $million)
Characteristics of a Disease Model
Global Biologics Drug Discovery Market, by phase, 2016-2025 (in $million)
Methods for Hybridoma Screening
Global Biologics Drug Discovery Market, Hit Generation, 2016-2025 (in $million)
Global Biologics Drug Discovery Market, Lead Identification, 2016-2025 (in $million)
Methods for humanization of antibodies
Global Biologics Drug Discovery Market, Lead Optimization, 2016-2025 (in $million)
Examples of Some of The Pharmaceutical Companies
Examples of Some of The Contract Research Organisations
Drug Market by manufacture type, 2016-2023 (in $million)
Global Biologics Drug Discovery Market, By Geography
Global Biologics Drug Discovery Market, 2016-2025, by geography (in $Million)
Global Biologics Drug Discovery Market, 2016-2025, North America (in $Million)
Global Biologics Drug Discovery Market, 2016-2025, North America, by Manufacture Type (in $Million)
The U.S. Biologics Drug Discovery Market Value, 2016-2025 ($Million)
Canada Biologics Drug Discovery Market Value, 2016-2025 ($Million)
Global Biologics Drug Discovery Market, 2016-2025, Europe (in $Million)
Global Biologics Drug Discovery Market, 2016-2025, Europe, by Manufacture Type (in $Million)
Germany Biologics Drug Discovery Market Value, 2016-2025 ($Million)
The U.K. Biologics Drug Discovery Market Value, 2016-2025 ($Million)
France Biologics Drug Discovery Market Value, 2016-2025 ($Million)
Switzerland Biologics Drug Discovery Market Value, 2016-2025 ($Million)
Rest of Europe Biologics Drug Discovery Market Value, 2016-2025 ($Million)
Global Biologics Drug Discovery Market, 2016-2025, Asia Pacific (in $Million)
Global Biologics Drug Discovery Market, 2016-2025, Asia Pacific, by Manufacture Type (in $Million)
Japan Biologics Drug Discovery Market Value, 2016-2025 ($Million)
China Biologics Drug Discovery Market Value, 2016-2025 ($Million)
India Biologics Drug Discovery Market Value, 2016-2025 ($Million)
Australia Biologics Drug Discovery Market Value, 2016-2025 ($Million)
Rest of Asia Pacific Biologics Drug Discovery Market Value, 2016-2025 ($Million)
AbbVie Inc.: Product Portfolio
AbbVie Inc. : Overall Financials (2014-2016)
AbbVie Inc.: Net Sales by Geographic Destination (2014-2016)
AbbVie Inc. : SWOT Analysis
Albany Molecular Research Inc.: Product/ Services Portfolio
Albany Molecular Research Inc.: Overall Financials
Albany Molecular Research Inc.: Net revenue by company segment
Albany Molecular Research Inc.: Contract Revenue by Geography
Albany Molecular Research Inc: SWOT Analysis
Allergan plc.: Product Portfolio
Allergan plc: Overall Financials (2014-2016)
Allergan plc: Net Sales by Business Segments (2015-2016)
Allergan plc: Net Sales by Business Segment (2014)
Allergan plc: SWOT Analysis
Amgen Inc.: Product Portfolio
Amgen Inc. : Overall Financials (2014-2016)
Amgen Inc. : Net Sales by Geographic Destination (2014-2016)
Amgen Inc. : SWOT Analysis
Aptuit: Product/Services Portfolio
Aptuit: SWOT Analysis
Astellas Pharma Inc.: Product Portfolio
Astellas Pharma Inc. : Overall Financials (2014-2016)
Astellas Pharma Inc. : Net Sales by Product Type (2014-2016)
Astellas Pharma Inc. : Net Sales by Geographic Destination (2014-2016)
Astellas Pharma Inc. : SWOT Analysis
AstraZeneca PLC: Product Portfolio
AstraZeneca PLC : Overall Financials, 2014-2016
AstraZeneca PLC : Net Revenue by Business Segment, 2014-2016
AstraZeneca PLC : Revenue across Different Geographies, 2014-2016
AstraZeneca PLC: SWOT Analysis
Bayer AG: Product Portfolio
Bayer AG : Overall Financials, 2014-2016
Bayer AG : Net Revenue by Business Segment, 2014-2016
Bayer AG: Net Revenue by Geographic Destination, 2014-2016
Bayer AG: SWOT Analysis
Biocon Ltd.: Product Portfolio
Biocon Ltd.: Overall Financials, 2015-2017
Biocon Ltd.: Net Revenue by Business Segment, 2015-2017
Biocon Ltd.: Net Revenue by Pharma Business Segment, 2014-2016
Biocon Ltd.: Revenue across Different Geographies, 2014-2016
Biocon Ltd.: SWOT Analysis
Boehringer Ingelheim GmbH : Product Portfolio
Boehringer Ingelheim GmbH : Overall Financials (2014-2016)
Boehringer Ingelheim GmbH : Net Sales by Product Type (2014-2016)
Boehringer Ingelheim GmbH : Net Sales by Geographic Destination (2014-2016)
Boehringer Ingelheim GmbH: SWOT Analysis
BRISTOL-MYERS SQUIBB COMPANY: Product Portfolio
BRISTOL-MYERS SQUIBB COMPANY: Overall Financials (2014-2016)
BRISTOL-MYERS SQUIBB COMPANY: Net Sales by Product Type (2014-2016)
BRISTOL-MYERS SQUIBB COMPANY: Net Sales by Geographic Destination (2014-2016)
BRISTOL-MYERS SQUIBB COMPANY: SWOT Analysis
Charles River Laboratories: Product/Services Portfolio
Charles River Laboratories: Overall Financials
Charles River Laboratories: Net sales by product segment
Charles River Laboratories: Net sales by Geography
Charles River Laboratories: SWOT Analysis
Eli Lilly and Company: Product Portfolio
Eli Lilly and Company : Overall Financials (2014-2016)
Eli Lilly and Company : Net Sales by Product Type (2014-2016)
Eli Lilly and Company : Net Sales by Geographic Destination (2014-2016)
Eli Lilly and Company: SWOT Analysis
Evotec AG: Product/Services Portfolio
Evotec AG : Overall Financials (2014-2016)
Evotec AG : Net Revenue by Business Segment
Evotec AG : Net Revenue by Region (2014-2016)
Evotec: SWOT Analysis
Roche AG: Product Portfolio
Roche AG: Overall Financials, (2013–2016)
Roche AG: Revenue across Different Geographies,
Roche AG: Net Revenue by Business Segment, (2013-2016)
Roche AG: SWOT Analysis
GenScript: Product/Services Portfolio
GenScript: SWOT Analysis
GILEAD SCIENCES, INC. : Product Portfolio
GILEAD SCIENCES, INC. : Overall Financials (2014-2016)
GILEAD SCIENCES, INC. : Net Sales by Geographic Destination (2014-2016)
GILEAD SCIENCES, INC. : SWOT Analysis
GSK: Product Portfolio
GSK: Overall Financials (2013-2016)
GSK: Net Revenue by Business Segments (2013-2016)
GSK: Net Revenue by Geography (2013-2015)
GSK: Net Revenue by Geography (2016)
GlaxoSmithKline Plc: SWOT Analysis
JOHNSON & JOHNSON: Product Portfolio
JOHNSON & JOHNSON: Overall Financials (2014-2016)
JOHNSON & JOHNSON : Net Revenue by Business Segment
JOHNSON & JOHNSON : Net Revenue by Region (2014-2016)
JOHNSON & JOHNSON: SWOT Analysis
Laboratory Corporation of America Holdings: Product/Services Portfolio
Laboratory Corporation of America Holdings: Overall Financials
Laboratory Corporation of America Holdings: Net sales by services segment
Laboratory Corporation of America Holdings: Net sales by Geography
Laboratory Corporation of America Holdings : SWOT Analysis
Merck & CO., Inc. KGaA: Overall Financials, (2014-2016)
Merck & CO., Inc. KGaA: Net Revenue by Business Segments, (2014-2016)
Merck & CO., Inc. KGaA: Net Revenue by Geography, (2014)
Merck & CO., Inc. KGaA: Net Revenue by Geography, (2015-2016)
Merck KGaA : SWOT Analysis
Merck & CO., Inc.: Product Portfolio
Merck & CO., Inc.: Overall Financials (2013-2016)
Merck & CO., Inc.: Net Revenue by Business Segments (2013-2014)
Merck & CO., Inc.: Net Revenue by Business Segments (2015-2016)
Merck & CO., Inc.: Net Revenue by Geography (2013-2014)
Merck & CO., Inc.: Net Revenue by Geography (2015-2016)
Merck & Co., Inc. : SWOT Analysis
Novartis: Product Portfolio
Novartis: Overall Financials (2013-2016)
Novartis: Net Revenue by Geography
Novartis: Net Revenue by Business Segments
Novartis: Net Revenue by Business Segments (2015-2016)
Novartis AG: SWOT Analysis
Novo Nordisk: Product Portfolio
Novo Nordisk: Overall Financials, 2014-2016
Novo Nordisk: Net Revenue by Business Segment, 2014-2016
Novo Nordisk: Revenue across Different Geographies, 2014-2016
NOVO Nordisk: SWOT Analysis
Pfizer: Product Portfolio
Pfizer: Overall Financials (2013-2016)
Pfizer: Net Revenue by Geography (2013-2016)
Pfizer: Net Revenue by Business Segments (2013-2014)
Pfizer: Net Revenue by Business Segments (2015-2016)
Pfizer Inc. : SWOT Analysis
Sanofi: Product Portfolio
Sanofi: Overall Financials (2014-2016)
Sanofi: Net Sales by Business Segments (2014-2016)
Sanofi: Net Sales by Geographic Destination (2014-2016)
Sanofi: Net Sales by Franchise (2014-2016)
Sanofi: SWOT Analysis
Teva Pharmaceutical Industries Limited: Product Portfolio
Teva Pharmaceutical Industries Limited: Overall Financials, (2013-2016)
Teva Pharmaceutical Industries Limited : Net Revenue by Business Segments, (2013-2016)
Teva Pharmaceutical Industries Limited: Net Revenue by Geography, (2013-2016)
Teva Pharmaceutical Industries Ltd.: SWOT Analysis
WuXi Apptec: Product/Services Portfolio
WuXi Apptec: SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report